“laura-shawver” Archives

in
Entry Author Date Location
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs 11/14/18 San Diego
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs 04/30/18 San Diego
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan 07/31/14 San Francisco
Big Data, Big Biology, and the ‘Tipping Point’ in Quantified Health 04/26/12 San Diego
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies 10/11/11 San Francisco
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks 10/26/10 San Diego
Anaphore Names 2 to Board 06/15/10 San Diego
Phenomix Diabetes Drug Dumped by Forest Labs, After Hitting Clinical Trial Goals 04/20/10 San Diego
Phenomix Strikes European Partnership for Diabetes Drug, Potentially Worth $163M 12/02/09 San Diego
SynergEyes Gets $13.3M, Carl Icahn Aims to Shake Up BiogenIdec Board, Layoffs Mount, & More San Diego BizTech News 02/09/09 San Diego
Phenomix Aims to Grab Piece of $10 Billion Diabetes Market 02/04/09 San Diego
Five Questions for the Future of Biotech in San Diego, Part 2 01/21/09 San Diego
Five Questions for the Future of Biotech in San Diego, Part 1 01/20/09 San Diego
Page 1 of 1